Superseded public profile

In clinical trials↗Metabolic↗

Superseded · version 2: Petrelintide↗

Related names recorded in this version: ZP8396↗

An amylin analogue candidate. This profile cites a ClinicalTrials.gov study record that was not yet recruiting.↗

This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.
Update · July 27, 2026

We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change. 1

What this version reported

ClinicalTrials.gov lists a Roche-sponsored combination study as not yet recruiting, updated July 7, 2026.↗

Organizations named in cited records:
  • Hoffmann-La Roche↗

Trial records: NCT07589686

Sources for this version

  1. 1
    Petrelintide With Enicepatide in Adults With Obesity or Overweight · record history version 3 · last update posted 2026-07-07 ↗

    ClinicalTrials.gov · Official source · Source checked July 22, 2026